Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the approval of ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), as a new first-line maintenance ...
See all of Stéphane Horel’s articles in Le Monde, Number 1 website for news. Newspaper articles and all the news, all the time: International, France, Society, Economy, Culture, Environment, etc.
The U.S. sold off a critical helium reserve despite decades of warnings — now, the war in Iran has exposed the consequences.